Existential and Solution-Focused Group Intervention for Older Adults (NCT07740005) | Clinical Trial Compass
CompletedNot Applicable
Existential and Solution-Focused Group Intervention for Older Adults
Turkey (Türkiye)26 participantsStarted 2025-05-05
Plain-language summary
This study aims to evaluate the effectiveness of an integrated existential and solution-focused group intervention enriched with narrative therapy techniques in promoting active aging among older adults. The intervention was developed to address psychosocial limitations associated with aging, including social isolation, role loss, ageism, and existential concerns.
The study employed an embedded mixed-methods randomized controlled design. Older adults aged 65 years and over who attended a primary healthcare mental health unit in a city, Türkiye, were randomly assigned to either an intervention group or a control group. Participants in the intervention group received a structured 10-session group program combining existential therapy, solution-focused approaches, and narrative therapy techniques. Quantitative data were collected using the World Health Organization Quality of Life-Old Module (WHOQOL-OLD) and the Active Aging Scale (AAS) at baseline, post-intervention, and three-month follow-up. Qualitative data were obtained through session transcripts and field notes to explore participants' experiences and the intervention process.
Who can participate
Age range
65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Aged 65 years or older. Registered at the mental health unit of the participating primary healthcare center.
Able to communicate effectively and participate in group sessions. Sufficient cognitive functioning to complete interviews and study assessments. Willing to participate voluntarily and provide written informed consent.
Exclusion Criteria:
Presence of severe psychiatric disorders that could interfere with participation in the group intervention.
Presence of neurological disorders associated with significant cognitive impairment.
Severe physical health problems preventing attendance at group sessions. Inability or unwillingness to complete the intervention or study assessments.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
World Health Organization Quality of Life Older Adults Module (WHOQOL OLD)
Timeframe: Baseline, immediately after the 10-week intervention, and 3 months after the intervention